Founded in 2009, Cleveland HeartLab specializes in cardiovascular disease prevention, diagnosis, and management. They provide a range of biomarker tests, including those focused on managing inflammation. Their CAP-accredited and CLIA-certified clinical reference laboratory receives samples from doctors' offices and hospitals across North America. Cleveland HeartLab also conducts research and development for next-generation cardiovascular disease biomarkers. Their innovative and medically relevant biomarkers are used by practitioners worldwide for heart disease prevention. Additionally, they hold exclusive intellectual property targeting under-addressed markets and are ISO 13485 certified.